Confidence Beyond Compliance
PharmaLex views the non-clinical portion of drug development as an opportunity to gain truly valuable information, as well as to help clients achieve new milestones. PharmaLex helps clients create the best non-clinical program given the drug candidate and the company’s goals, with a longer-term view toward optimizing the gathering of useful data. Discovery chemistry / biology needs to be combined with regulatory support to ensure the start of a new pharmaceutical drug takes into consideration regulatory compliance at the earliest opportunity. In an ever-changing regulatory environment, the role of regulatory affairs personnel is essential, ensuring compliance with legislation in all regions in which a company wishes to develop its drug is secured.